News
17h
GlobalData on MSNNovo Nordisk defeated in Wegovy patent dispute by ViatrisThe Delaware court ruled that Viatris’ drug does not infringe the "administered without another therapeutic agent" limitation ...
After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic versions of Novo Nordisk’s lucrative semaglutide drugs for diabetes and obesi | ...
What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...
Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a ...
12h
Verywell Health on MSNWhat Happens to Your Body When You Stop Taking OzempicMany people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to know before stopping.
WEIGHT loss jabs could help control asthma symptoms in obese people, a study suggests – and it’s not just about losing weight ...
Explore more
Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...
Researchers says the drugs could be a treatment for obese people with asthma who are ‘often resistant’ to steroids ...
The new novel, out July 29 from Flatiron Books, follows a group of mothers whose children are enrolled at the ...
An NHS surgeon has delivered his 'hot take' on why weight-loss jabs like Wegovy and Mounjaro are causing 'Ozempic babies' to be born.
13h
Wisconsin Watch on MSNDid drug companies spend $10 billion on consumer advertising in 2024, making up nearly 25% of evening ad minutes?Yes. A quarter of the ad minutes that ran during the evening news in the first five months of this year were from pharmaceutical companies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results